Literature DB >> 6680222

The relationship between heating time and temperature: its relevance to clinical hyperthermia.

S B Field, C C Morris.   

Abstract

It is well known that for a given level of damage to either cells in vitro or tissues in situ the relationship between temperature and time of application undergoes a transition in the range 42-43 degrees C and that above this temperature a change of 1 degree C is equivalent to a change in heating time by a factor of two. The present study has concentrated on establishing the relationship between time and temperature over a wide range. The investigation is in two parts, i.e. a review of the literature and an experimental study in which the endpoint used was necrosis in the tail of the baby rat. The aim is to provide information which might help solve a major clinical problem, namely the lack of a satisfactory means of relating treatments given with different temperatures for different lengths of time. The difficulty arises because there is no satisfactory definition of heat dose, in this context. The results confirm the relationship given above for temperatures above the transition. However, below the transition a change of 1 degree C is equivalent to a change in heating time by a factor of six. It is suggested that these relationships provide a means of monitoring a treatment in which the temperature does not remain constant and may vary within a heated volume. The method may also be used to compare treatments from different centres. An indication of the considerable uncertainties of the procedure is given.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1983        PMID: 6680222     DOI: 10.1016/s0167-8140(83)80020-6

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  18 in total

Review 1.  InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity.

Authors:  Feifan Zhou; Xiaosong Li; Mark F Naylor; Tomas Hode; Robert E Nordquist; Luciano Alleruzzo; Joseph Raker; Samuel S K Lam; Nan Du; Lei Shi; Xiuli Wang; Wei R Chen
Journal:  Cancer Lett       Date:  2015-01-26       Impact factor: 8.679

2.  THERMAL DOSE REQUIREMENT FOR TISSUE EFFECT: EXPERIMENTAL AND CLINICAL FINDINGS.

Authors:  Mark W Dewhirst; Benjamin L Viglianti; Michael Lora-Michiels; P Jack Hoopes; Margaret Hanson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2003-06-02

Review 3.  Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?

Authors:  Laura A Lambert; Ariana Harris
Journal:  J Gastrointest Oncol       Date:  2016-02

4.  Heat distribution of polymerisation temperature of bone cement on the spinal canal during vertebroplasty.

Authors:  Bernd Wegener; Nicole Zolyniak; Mehmet F Gülecyüz; Andreas Büttner; Christoph von Schulze Pellengahr; Veronika Schaffer; Volkmar Jansson; Christof Birkenmaier
Journal:  Int Orthop       Date:  2011-10-29       Impact factor: 3.075

5.  Improved Hyperthermia Treatment of Tumors Under Consideration of Magnetic Nanoparticle Distribution Using Micro-CT Imaging.

Authors:  H Dähring; J Grandke; U Teichgräber; I Hilger
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

6.  Efficacy and hazards of 425 nm oral cavity light dosing to inactivate SARS-CoV-2.

Authors:  Max A Stockslager; Jacob F Kocher; Leslee Arwood; Nathan Stasko; Rebecca A McDonald; Mark A Tapsak; David Emerson
Journal:  J Dent       Date:  2022-06-17       Impact factor: 4.991

Review 7.  Challenges to effective cancer nanotheranostics.

Authors:  Marites P Melancon; R Jason Stafford; Chun Li
Journal:  J Control Release       Date:  2012-08-18       Impact factor: 9.776

8.  Monitoring nanoparticle-mediated cellular hyperthermia with a high-sensitivity biosensor.

Authors:  Amarnath Mukherjee; Mark Castanares; Mohammad Hedayati; Michele Wabler; Bruce Trock; Prakash Kulkarni; Ronald Rodriguez; Robert H Getzenberg; Theodore L DeWeese; Robert Ivkov; Shawn E Lupold
Journal:  Nanomedicine (Lond)       Date:  2014-12       Impact factor: 5.307

9.  CEM43°C thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels?

Authors:  Gerard C van Rhoon; Theodoros Samaras; Pavel S Yarmolenko; Mark W Dewhirst; Esra Neufeld; Niels Kuster
Journal:  Eur Radiol       Date:  2013-04-04       Impact factor: 5.315

10.  Protein-passivated Fe(3)O(4) nanoparticles: low toxicity and rapid heating for thermal therapy.

Authors:  Bappaditya Samanta; Haoheng Yan; Nicholas O Fischer; Jing Shi; D Joseph Jerry; Vincent M Rotello
Journal:  J Mater Chem       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.